SOPHiA GENETICS SA - Ordinary Shares (NQ:SOPH)

7.732 +0.192 (+2.54%)

Delayed Quote Updated: 2:51 PM EDT, Oct 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about SOPHiA GENETICS SA - Ordinary Shares

< Previous 1 2 3 4 Next >

Acutis Diagnostics Leverages SOPHiA GENETICS Technology to Create New Next Generation Sequencing Test

March 28, 2023

From SOPHiA GENETICS

Via Business Wire

Why Bed Bath & Beyond Shares Are Trading Lower By Around 24%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 20, 2023

Gainers

Via Benzinga

Sophia Genetics: Q2 Earnings Insights ↗

August 09, 2022

Sophia Genetics (NASDAQ:SOPH) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

April 08, 2022

During Friday's morning session, 234 stocks hit new 52-week lows. Interesting Facts About Today's 52-Week Lows: The largest company in terms of market cap...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

March 25, 2022

On Friday, 166 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 20, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

March 14, 2023

Via Benzinga

SOPHiA GENETICS and Agilent Partner on Comprehensive Solution for Cancer Analysis

March 14, 2023

From SOPHiA GENETICS

Via Business Wire

SOPHiA GENETICS Reports Fourth Quarter and Year End 2022 Financial Results

March 07, 2023

From SOPHiA GENETICS SA

Via Business Wire

University of Arkansas for Medical Sciences Will Use SOPHiA GENETICS to Advance Clinical Research for Blood Cancers

March 06, 2023

From SOPHiA GENETICS

Via Business Wire

SOPHiA GENETICS Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2023

March 03, 2023

From SOPHiA GENETICS

Via Business Wire

SOPHiA GENETICS and QIAGEN Forge Partnership to Combine Strengths in Next-generation Sequencing

March 01, 2023

From SOPHiA GENETICS

Via Business Wire

Synergy Laboratories Taps SOPHiA GENETICS Technology for New Cancer Profiling Solution

February 28, 2023

From SOPHiA GENETICS

Via Business Wire

SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full Year of Fiscal 2022 on March 7, 2023

February 23, 2023

From SOPHiA GENETICS

Via Business Wire

SOPHiA GENETICS Expands Partnership With AstraZeneca to Include Multimodal Approaches for Cancer Drug Development

February 13, 2023

From SOPHiA GENETICS

Via Business Wire

SOPHiA GENETICS and Leading US Cancer Center Collaborate to Combine Cancer Analysis Technology for Liquid Biopsies

January 10, 2023

From SOPHiA GENETICS

Via Business Wire

SOPHiA GENETICS to Present at the J.P. Morgan 2023 Healthcare Conference

January 04, 2023

From SOPHiA GENETICS

Via Business Wire

SOPHiA GENETICS Reports Financial Results for the Third Quarter of Fiscal 2022

November 08, 2022

Sustainable growth momentum evident despite foreign exchange headwinds

From SOPHiA GENETICS, Inc.

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Wednesday ↗

November 09, 2022

On Wednesday, 283 companies set new 52-week lows.

Via Benzinga

SOPHiA GENETICS to Participate in Upcoming November Investor Conferences

November 04, 2022

From SOPHiA GENETICS, Inc.

Via GlobeNewswire

SOPHiA GENETICS to Announce Financial Results for the Third Quarter of Fiscal 2022 on November 8, 2022

October 06, 2022

From SOPHiA GENETICS, Inc.

Via GlobeNewswire

Why Is Ceragon Networks Surging By 19%? 41 Stocks Moving In Tuesday's Mid-Day Session ↗

June 28, 2022

Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) jumped 88.9% to $2.3986. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.

Via Benzinga

Earnings Scheduled For August 9, 2022 ↗

August 09, 2022

Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.

Via Benzinga

63 Biggest Movers From Yesterday ↗

June 17, 2022

Gainers Advent Technologies Holdings, Inc. (NYSE: ADN) shares surged 244% to close at $3.99 on Thursday after the company announced it received notification of euro 782.1 million of funding from the...

Via Benzinga

37 Stocks Moving In Thursday's Mid-Day Session ↗

June 16, 2022

Gainers Advent Technologies Holdings, Inc. (NYSE: ADN) shares jumped 153% to $2.94 after the company announced it received notification of euro 782.1 million of funding from the Greek State for the...

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

June 06, 2022

Monday's session saw 84 companies set new 52-week lows.

Via Benzinga

27 Recession-Resistant Stocks To Look At Now ↗

May 09, 2022

When we enter a period of economic uncertainty, the phrase "recession-proof stocks" is tossed about, but really the only certainty is that recession-proof stocks do not...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

June 01, 2022

On Wednesday, 73 stocks hit new 52-week lows.

Via Benzinga

Earnings Scheduled For May 10, 2022 ↗

May 10, 2022

Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

March 28, 2022

On Monday, 147 stocks hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.